Biomarker Testing Discussion Panel

Comprehensive biomarker testing can play an important role in the personalized treatment for patients with non-small cell lung cancer (NSCLC).

In honor of Lung Cancer Awareness Month 2021, the Association of Community Cancer Centers (ACCC) and Amgen co-hosted a live discussion with a panel of multidisciplinary oncology experts, focusing on the hurdles cancer care teams face when implementing biomarker testing for patients and what can be done to ease these burdens The panelists explored the treatment landscape of NSCLC, the importance of comprehensive biomarker testing to inform decision-making, and effective practices on how to incorporate biomarker testing into your cancer program.

Watch the full-length panel discussion which originally aired live on November 1, 2021.

Video Clips

These short video segments from the full-length panel discussion provide concise and informative learning when time is limited. Hear insights in relation to specific aspects of biomarker testing for patients with non-small cell lung cancer.

Related Resources

• Biomarker Testing Implementation Roadmap for Advanced NSCLC
  An innovative learning tool that can help multidisciplinary cancer care teams lay the groundwork for biomarker testing, train and prepare care teams to offer testing, implement testing, and evaluate ongoing progress.
• Resource Library
  Accompanying resources from the Roadmap are accessible in the digital Resource Library. Search by roadmap component, keyword, or audience (providers and patients).
• Increasing Communication and Collaboration Among Cancer Care Teams to Improve Biomarker Testing in NSCLC
  Read about efforts to demystify the process and help everyone – from oncologists and nursing staff to the electronic medical record managers and administrative team – to have the information and tools to successfully implement biomarker testing for their patients.
• NSCLC Biomarker Testing Roadmap Infographic
  This simple infographic outlines the simple steps that cancer center staff can take towards successful and sustained biomarker testing implementation.